Company Overview and News


Add PNO
to your dashboard

Headline News

Calidus Resources bags $10M to accelerate Pilbara Goldfield exploration

2017-09-27 proactiveinvestors.com.au
Calidus Resources Limited (ASX:CAI) has successfully raised $10 million via a share placement to both new and existing institutional and sophisticated investors at an issue price of $0.041 per share. (2-0)

Calidus raises $10m for gold project

2017-09-27 businessnews.com.au
Local gold explorer Calidus Resources has tapped investors for $10 million as it progresses development of its Warrawoona project in the Pilbara.

Calidus debuts on ASX

2017-06-22 businessnews.com.au
Gold-focused Calidus Resources has begun trading on the ASX after raising $7.8 million from investors and completing a reverse takeover of biotech company Pharmanet Group.

ASX Capital Raising Complete

2017-06-05 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company is pleased to announce that it has today received notice that Pharmanet Group Limited, to be renamed Calidus Resources Limited, has been notified that all funds have been received pursuant to the ASX Capital Raising as previously announced. These funds total A$7,875,000 (£4.5million).

Conditional Approval for Calidus Resources Listing

2017-06-01 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company is pleased to advise that the ASX has today given conditional approval for the shares of Pharmanet Group Limited ("Pharmanet"), to be reinstated to trading on the ASX.  As previously announced, upon restoration, Pharmanet will be renamed Calidus Resources Limited ("Calidus").

Approval for Pharmanet Group to acquire Keras Gold

2017-05-30 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company is pleased to advise that shareholders of Pharmanet Group Limited ("Pharmanet") have approved all the resolutions associated with the acquisition of 100% of the issued share capital of the Company's wholly owned subsidiary Keras (Gold) Australia Pty Ltd ("Keras Australia") at a general meeting of shareholders held today in Perth, Australia.

Result of General Meeting

2017-05-24 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company, is pleased to announce that all resolutions were passed at the General Meeting of the Company held earlier today.

Interim Results

2017-05-22 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company, is pleased to announce its interim results for the six months ended 31 March 2017.

Lodged Prospectus for ASX Listing

2017-05-08 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company, is pleased to confirm that ASX quoted Pharmanet Group Limited ("Pharmanet") lodged a prospectus with the Australian Securities and Investments Commission (the "Prospectus") on 5 May 2017.  The Prospectus has been lodged in order to raise A$7.8 million (approximately £4.6 million) (the "ASX Capital Raising") as part of the proposed acquisition by Pharmanet of 100% of the issued share capital of the Company's wholly owned subsidiary Keras (Gold) Australia Pty Ltd ("Keras Australia") as previously announced on 21 March 2017 (the "Transaction").

Notice of General Meeting & Corporate Update

2017-04-28 londonstockexchange
Keras Resources plc, the AIM listed mineral resource company, announces that a circular and Notice of General Meeting will be posted to shareholders on 2 May 2017 ("the Circular") relating to the proposed acquisition by Pharmanet Group Limited ("Pharmanet") of 100% of the issued share capital of the Company's wholly owned subsidiary Keras (Gold) Australia Pty Ltd ("Keras Australia") as previously announced on 21 March 2017 (the "Transaction").

?530,000 Placing & appointment of Joint Brokers

2017-04-24 londonstockexchange
Keras Resources plc is pleased to announce that it has raised £530,000 (before expenses) from new and existing shareholders through the placing of 151,428,560 ordinary shares of 0.1p each ('Ordinary Shares') at a placing price of 0.35p per Ordinary Share (the 'Placing Shares') and the grant of 75,714,280 warrants to subscribe for new Ordinary Shares (the 'Placing Warrants') (together the 'Placing').

Oversubscribed Placing to Support ASX Listing

2017-04-18 londonstockexchange
Keras Resources plc is pleased to announce that Pharmanet Group Limited ("Pharmanet") (ASX: PNO), the ASX listed company which the Company will reverse its wholly owned gold subsidiary, Keras (Gold) Australia Pty Ltd ("Keras Australia") into, has successfully raised A$620,000 (before expenses) from sophisticated investors in Australia (the "Placing").  

Pharmanet to relist as gold company

2017-03-22 businessnews.com.au
Dormant Perth-based biotech company Pharmanet Group will re-emerge as a gold explorer after entering into an agreement to acquire Keras Australia by way of a reverse takeover.

Shareholder and Analyst Conference Call

2017-03-21 londonstockexchange
Keras Resources plc is pleased to announce that it will be holding a shareholder and analyst conference call on Wednesday 22 March 2017 at 10.30 am GMT.  During the call, Managing Director, Dave Reeves will be discussing the proposed listing of the Company's gold assets on the Australian Stock Exchange via the transaction under which Keras (Gold) Australia Pty Ltd ("Keras Australia") will be sold to  Pharmanet Group Limited ("Pharmanet") by an exchange of shares, which was announced earlier today (the "Transaction").